blenrep
glaxosmithkline (ireland) limited - belantamab mafodotin - myeloma multiplex - daganatellenes szerek - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
xenpozyme
sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - egyéb táplálkozási traktus pedig anyagcsere termékek, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.
diltiazem-b 120 mg retard filmtabletta
biogal-teva pharma rt. (régi) - diltiazem -
statonex 10 mg filmtabletta
menarini international operations luxembourg sa - szimvasztatin -
statonex 20 mg filmtabletta
menarini international operations luxembourg sa - szimvasztatin -
statonex 40 mg filmtabletta
menarini international operations luxembourg sa - szimvasztatin -
diltiazem-b 60 mg filmtabletta
biogal-teva pharma rt. (régi) - diltiazem -
diltiazem-b 30 mg filmtabletta
biogal-teva pharma rt. (régi) - diltiazem -
depakine chrono 500 mg retard filmtabletta
sanofi-aventis zrt. - valproinsav; nátrium-valproát -
depakine 100 mg/ml por és oldószer oldatos injekcióhoz
sanofi-aventis zrt. - valproinsav -